Epithelial ingrowth after LASIK

Clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift

Christopher R. Henry, Ana Paula Canto, Anat Galor, Pravin K. Vaddavalli, William W Culbertson, Sonia H Yoo

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

PURPOSE: To describe clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift for epithelial ingrowth following LASIK. METHODS: Consecutive, noncomparative, retrospective case series of eyes requiring flap lift for epithelial ingrowth following LASIK from June 2003 through July 2011 at a tertiary care, university-based eye hospital. Main outcome measures were uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) at 1 and 3 months and recurrence of epithelial ingrowth. RESULTS: Forty-five eyes were included. Laser in situ keratomileusis retreatment was the most common etiologic factor for epithelial ingrowth (28/45 eyes [62%]). All patients were treated with flap lift and scraping. Mean logMAR UDVA at presentation was 0.28 (Snellen equivalent 20/38). Mean logMAR UDVA at 3 months was 0.17 (Snellen equivalent 20/30) with 53% of eyes 20/25 or better. Mean logMAR CDVA at 3 months was 0.06 (Snellen equivalent 20/23) with 78% of eyes 20/25 or better. Epithelial ingrowth into the central cornea portended a trend towards UDVA worse than 20/25 or worse at 3-month follow-up (hazard ratio [HR] 5.54, 95% confidence interval [CI]: 0.98-31.3, P=.05) and CDVA worse than 20/25 at 3-month follow-up (HR 4.32, 95% CI: 0.85-21.9, P=.08). Recurrence after treatment was 31% at 3 months and 36% at 1 year. Risk factors for recurrence included: infectious etiology of ingrowth (HR 5.7, 95% CI: 1.11-29.1, P=.04), use of microkeratome for primary LASIK (HR 4.64, 95% CI: 1.07-20.1, P=.04), and hyperopic primary LASIK (HR 2.49, 95% CI: 0.98-6.31, P=.06). CONCLUSIONS: Patients undergoing flap lift for the treatment of epithelial ingrowth have a relatively high rate of recurrence but good visual acuity outcomes.

Original languageEnglish
Pages (from-to)488-492
Number of pages5
JournalJournal of Refractive Surgery
Volume28
Issue number7
DOIs
StatePublished - Jul 1 2012

Fingerprint

Laser In Situ Keratomileusis
Visual Acuity
Confidence Intervals
Recurrence
Retreatment
Tertiary Healthcare
Cornea
Outcome Assessment (Health Care)
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology
  • Surgery

Cite this

Epithelial ingrowth after LASIK : Clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift. / Henry, Christopher R.; Canto, Ana Paula; Galor, Anat; Vaddavalli, Pravin K.; Culbertson, William W; Yoo, Sonia H.

In: Journal of Refractive Surgery, Vol. 28, No. 7, 01.07.2012, p. 488-492.

Research output: Contribution to journalArticle

@article{bd9b8d1895c3443c97c352649fe0c344,
title = "Epithelial ingrowth after LASIK: Clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift",
abstract = "PURPOSE: To describe clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift for epithelial ingrowth following LASIK. METHODS: Consecutive, noncomparative, retrospective case series of eyes requiring flap lift for epithelial ingrowth following LASIK from June 2003 through July 2011 at a tertiary care, university-based eye hospital. Main outcome measures were uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) at 1 and 3 months and recurrence of epithelial ingrowth. RESULTS: Forty-five eyes were included. Laser in situ keratomileusis retreatment was the most common etiologic factor for epithelial ingrowth (28/45 eyes [62{\%}]). All patients were treated with flap lift and scraping. Mean logMAR UDVA at presentation was 0.28 (Snellen equivalent 20/38). Mean logMAR UDVA at 3 months was 0.17 (Snellen equivalent 20/30) with 53{\%} of eyes 20/25 or better. Mean logMAR CDVA at 3 months was 0.06 (Snellen equivalent 20/23) with 78{\%} of eyes 20/25 or better. Epithelial ingrowth into the central cornea portended a trend towards UDVA worse than 20/25 or worse at 3-month follow-up (hazard ratio [HR] 5.54, 95{\%} confidence interval [CI]: 0.98-31.3, P=.05) and CDVA worse than 20/25 at 3-month follow-up (HR 4.32, 95{\%} CI: 0.85-21.9, P=.08). Recurrence after treatment was 31{\%} at 3 months and 36{\%} at 1 year. Risk factors for recurrence included: infectious etiology of ingrowth (HR 5.7, 95{\%} CI: 1.11-29.1, P=.04), use of microkeratome for primary LASIK (HR 4.64, 95{\%} CI: 1.07-20.1, P=.04), and hyperopic primary LASIK (HR 2.49, 95{\%} CI: 0.98-6.31, P=.06). CONCLUSIONS: Patients undergoing flap lift for the treatment of epithelial ingrowth have a relatively high rate of recurrence but good visual acuity outcomes.",
author = "Henry, {Christopher R.} and Canto, {Ana Paula} and Anat Galor and Vaddavalli, {Pravin K.} and Culbertson, {William W} and Yoo, {Sonia H}",
year = "2012",
month = "7",
day = "1",
doi = "10.3928/1081597X-20120604-01",
language = "English",
volume = "28",
pages = "488--492",
journal = "Journal of Refractive Surgery",
issn = "1081-597X",
publisher = "Slack Incorporated",
number = "7",

}

TY - JOUR

T1 - Epithelial ingrowth after LASIK

T2 - Clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift

AU - Henry, Christopher R.

AU - Canto, Ana Paula

AU - Galor, Anat

AU - Vaddavalli, Pravin K.

AU - Culbertson, William W

AU - Yoo, Sonia H

PY - 2012/7/1

Y1 - 2012/7/1

N2 - PURPOSE: To describe clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift for epithelial ingrowth following LASIK. METHODS: Consecutive, noncomparative, retrospective case series of eyes requiring flap lift for epithelial ingrowth following LASIK from June 2003 through July 2011 at a tertiary care, university-based eye hospital. Main outcome measures were uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) at 1 and 3 months and recurrence of epithelial ingrowth. RESULTS: Forty-five eyes were included. Laser in situ keratomileusis retreatment was the most common etiologic factor for epithelial ingrowth (28/45 eyes [62%]). All patients were treated with flap lift and scraping. Mean logMAR UDVA at presentation was 0.28 (Snellen equivalent 20/38). Mean logMAR UDVA at 3 months was 0.17 (Snellen equivalent 20/30) with 53% of eyes 20/25 or better. Mean logMAR CDVA at 3 months was 0.06 (Snellen equivalent 20/23) with 78% of eyes 20/25 or better. Epithelial ingrowth into the central cornea portended a trend towards UDVA worse than 20/25 or worse at 3-month follow-up (hazard ratio [HR] 5.54, 95% confidence interval [CI]: 0.98-31.3, P=.05) and CDVA worse than 20/25 at 3-month follow-up (HR 4.32, 95% CI: 0.85-21.9, P=.08). Recurrence after treatment was 31% at 3 months and 36% at 1 year. Risk factors for recurrence included: infectious etiology of ingrowth (HR 5.7, 95% CI: 1.11-29.1, P=.04), use of microkeratome for primary LASIK (HR 4.64, 95% CI: 1.07-20.1, P=.04), and hyperopic primary LASIK (HR 2.49, 95% CI: 0.98-6.31, P=.06). CONCLUSIONS: Patients undergoing flap lift for the treatment of epithelial ingrowth have a relatively high rate of recurrence but good visual acuity outcomes.

AB - PURPOSE: To describe clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift for epithelial ingrowth following LASIK. METHODS: Consecutive, noncomparative, retrospective case series of eyes requiring flap lift for epithelial ingrowth following LASIK from June 2003 through July 2011 at a tertiary care, university-based eye hospital. Main outcome measures were uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) at 1 and 3 months and recurrence of epithelial ingrowth. RESULTS: Forty-five eyes were included. Laser in situ keratomileusis retreatment was the most common etiologic factor for epithelial ingrowth (28/45 eyes [62%]). All patients were treated with flap lift and scraping. Mean logMAR UDVA at presentation was 0.28 (Snellen equivalent 20/38). Mean logMAR UDVA at 3 months was 0.17 (Snellen equivalent 20/30) with 53% of eyes 20/25 or better. Mean logMAR CDVA at 3 months was 0.06 (Snellen equivalent 20/23) with 78% of eyes 20/25 or better. Epithelial ingrowth into the central cornea portended a trend towards UDVA worse than 20/25 or worse at 3-month follow-up (hazard ratio [HR] 5.54, 95% confidence interval [CI]: 0.98-31.3, P=.05) and CDVA worse than 20/25 at 3-month follow-up (HR 4.32, 95% CI: 0.85-21.9, P=.08). Recurrence after treatment was 31% at 3 months and 36% at 1 year. Risk factors for recurrence included: infectious etiology of ingrowth (HR 5.7, 95% CI: 1.11-29.1, P=.04), use of microkeratome for primary LASIK (HR 4.64, 95% CI: 1.07-20.1, P=.04), and hyperopic primary LASIK (HR 2.49, 95% CI: 0.98-6.31, P=.06). CONCLUSIONS: Patients undergoing flap lift for the treatment of epithelial ingrowth have a relatively high rate of recurrence but good visual acuity outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84864505583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864505583&partnerID=8YFLogxK

U2 - 10.3928/1081597X-20120604-01

DO - 10.3928/1081597X-20120604-01

M3 - Article

VL - 28

SP - 488

EP - 492

JO - Journal of Refractive Surgery

JF - Journal of Refractive Surgery

SN - 1081-597X

IS - 7

ER -